[HTML][HTML] Immunotherapy in Hodgkin lymphoma: present status and future strategies

TP Vassilakopoulos, C Chatzidimitriou… - Cancers, 2019 - mdpi.com
Although classical Hodgkin lymphoma (cHL) is usually curable, 20–30% of the patients
experience treatment failure and most of them are typically treated with salvage …

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies.

TP Vassilakopoulos, C Chatzidimitriou… - Cancers, 2019 - europepmc.org
Although classical Hodgkin lymphoma (cHL) is usually curable, 20–30% of the patients
experience treatment failure and most of them are typically treated with salvage …

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies

C Chatzidimitriou, JV Asimakopoulos, M Arapaki… - …, 2019 - search.proquest.com
Although classical Hodgkin lymphoma (cHL) is usually curable, 20–30% of the patients
experience treatment failure and most of them are typically treated with salvage …

[PDF][PDF] Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies

TP Vassilakopoulos, C Chatzidimitriou… - pdfs.semanticscholar.org
Although classical Hodgkin lymphoma (cHL) is usually curable, 20–30% of the patients
experience treatment failure and most of them are typically treated with salvage …

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies.

TP Vassilakopoulos, C Chatzidimitriou… - …, 2019 - search.ebscohost.com
Although classical Hodgkin lymphoma (cHL) is usually curable, 20–30% of the patients
experience treatment failure and most of them are typically treated with salvage …

[HTML][HTML] Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies

TP Vassilakopoulos, C Chatzidimitriou… - Cancers, 2019 - ncbi.nlm.nih.gov
Although classical Hodgkin lymphoma (cHL) is usually curable, 20–30% of the patients
experience treatment failure and most of them are typically treated with salvage …

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies

TP Vassilakopoulos, C Chatzidimitriou… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Although classical Hodgkin lymphoma (cHL) is usually curable, 20-30% of the patients
experience treatment failure and most of them are typically treated with salvage …